Ben Kovler

Cannabis Stocks Cronos, Trulieve, Green Thumb, Verano Trading Up After Earnings: A Full Recap
Cannabis Co. Cansortium Refinances Debt With $96.5M Loan Ahead Of Major Merger And Next Phase Of Growth
Agrify's Q3 Revenue Drop, $18.6M Loss Amid New Leadership
Cannabis Co. Cansortium Refinances Debt With $96.5M Loan Ahead Of Major Merger And Next Phase Of Growth
Agrify's Q3 Revenue Drop, $18.6M Loss Amid New Leadership
Green Thumb Grows Revenue To $287M In Q3, Expands Cannabis Retail Network
Cannabis Giant Green Thumb Confirms $50M Share Repurchase Program, CEO Open To M&A And 'Unique Investments'

Ben Kovler Recent News

Rumors Of Green Thumb And Boston Beer Merger: What Investors Need to Know, Analyst Breaks It Down
Green Thumb Industries (OTC: GTBIF) has expressed interest in merging with Boston Beer (NYSE: SAM), according to a recent report by Pablo Zuanic of Zuanic & Associates. What strategic advantages does this merger offer?
Chicago Cannabis Company Green Thumb Proposes Merger With Boston Beer, Eyes Stock Listing
Green Thumb writes a letter to Boston Beer seeking a merger to gain access to NYSE and develop innovative cannabis-infused products. Read now!
Green Thumb Industries Revenue Increases 11% In Q1 2024: We're 'Off To A Great Start,' Says Pres
'As we round out our tenth year as a company, we believe we have a clear vision, a healthy balance sheet and the best team in the business to execute the next decade of the Green Thumb story,' said CEO Ben Kovler.
Green Thumb Industries Reports Q3 2023 Revenue Growth And 'Strong Profitability'
Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of RISE Dispensaries, announced its Q3 2023 financial results, which ended September 30, 2023.
35,000 Share Divorce Deal & Legal Hurdles: Is Green Thumb Cannabis' Stock In Question?
Legal Fees Denied in Edible Arrangements Name Dispute
Who's Who In Cannabis: Latest Executive Changes You Should Know About
Green Thumb Strengthens Board Of Directors
Chicago Cannabis Giant Announces Stock Buyback Plan: It Was 'In Works' Before HHS Call To Reschedule Marijuana, CEO Says
Green Thumb Industries Inc.
Medical Marijuana Giants Lambaste NY Gov. Hochul For Weed Rollout Mess, Seek Licenses To Sell Recreational Weed
Four major medical marijuana retailers in New York sent a letter to Gov.
Green Thumb Q2 Revenue Declines 0.8% YoY, What About Income?
Green Thumb Industries Inc. (OTCQX: GTBIF) (CSE:GTII) released its financial results for the second quarter ended June 30, 2023, revealing revenue of $252.4 million a decrease of 0.8% compared to $254.3 million in Q2 2022, and an increase of 2% compared to $248.5 million in Q1
'Controlled Substances Act Was An Ill-Conceived, Targeted Policy,' RISE Dispensaries Launch 'Thanks, Dick' Campaign
RISE Dispensaries, a cannabis retail chain owned by Green Thumb Industries Inc. (OTCQX: GTBIF) (CSE:GTII), announced the launch of its “Thanks, Dick” campaign, which will roll out across RISE Dispensaries in select markets on Ju
Here's Where To Buy Weed Over Memorial Day Weekend: New Cannabis Shops Open In Five States
Body and Mind Expands In Illinois Body and Mind Inc. (CSE: BAMM) (OTCQB: BMMJ) announced the grand opening of a new store in Markham, Illinois, over the Memorial Day weekend.
Green Thumb Industries Reports Q1 2023 Financials: Revenue Up 2% YoY To $249M, Adjusted EBITDA?
Green Thumb Industries Inc. (OTCQX: GTBIF) reported its financial results for the first quarter that ended March 31, 2023.
Exclusive: Dogwalkers Launches Travel-Ready Cannabis Infused Pre-Rolls Show Dogs: Each Purchase Supports Animals In Need
Dogwalkers, a premium cannabis pre-roll brand from Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF) is launching Show Dogs, a new line of infused cannabis pre-rolls.
Key Marijuana Executive Changes: Who Will Lead MariMed After CEO's Passing? MJBiz CEO Steps Down
MJBiz CEO To Step Down Marijuana Business Daily's Chris Walsh will step down as CEO in January.
Booker Blasts McConnell For Halting Marijuana Reform And Saying 'Poison Pills' Shouldn't Be Part Of Bill
New Jersey Senator Cory Booker thinks that Senate minority leader Mitch McConnell is significantly impacting his Senate colleagues to oppose passing any cannabis-related bills in the lame-duck session.
Green Thumb Posts Nearly 15% Rise In Q2 Revenue, Thank You New Jersey And Illinois
Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF) reported its financial results for the second quarter ended June 30, 2022.  Highlights for the second quarter and six months ended June 30, 2022:
Innovative Industrial Properties Expands Real Estate Partnership With Green Thumb Industries At Pennsylvania Property
Innovative Industrial Properties, Inc. (NYSE: IIPR) entered into an amendment of the lease with Green Thumb Industries Inc. (OTCQX: GTBIF) (CSE:GTII) The lease amendment in Danville, Pennsylvania, provided $55.0 m
Green Thumb Industries Opens Third Round Of Its Good Green Grant Applications
Green Thumb Industries Inc. (OTCQX: GTBIF) (CSE:GTII) opened applications for the third round of its Good Green Grant Program.
Green Thumb Industries Analyst On Q1 Earnings: Cannabis Grower Has Enough Cash To Fuel Growth
Green Thumb Industries Inc. (OTCQX: GTBIF) (CSE: GTII) reported its
Green Thumb Industries Reports Strong Q1, Ninth Consecutive Quarter Of Positive Cash Flow
Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF) has reported its financial results for the first quarter ended March 31, 2022.
Green Thumb Industries Announces Second Round Of Good Green Grant Recipients
Green Thumb Industries Inc. (OTCQX: GTBIF) (CSE: GTII) announced the second group of nonprofit organizations to receive funding as part of its Good Green Grant Program.
New Jersey: First Day Of Legal Weed Sales Has Many Celebrating
New Jersey weed enthusiasts started lining up before dawn at dispensaries Thursday across the Garden State as adult-use cannabis sales went into effect.
Cannabis Dispensary Roundup: Where To Buy Rec Marijuana In New Jersey, CBD Spas & More Store Openings
;

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2025 Benzinga | All Rights Reserved